Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IronWoMan: IV vs Oral Iron in Blood Donors
NCT01787526Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- Jun 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Medical University of Graz. Started Jun 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01787526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787526.